Jeffery N Epstein1, Kelly J Kelleher2, Rebecca Baum2, William B Brinkman3, James Peugh3, William Gardner4, Phil Lichtenstein5, Joshua M Langberg6. 1. Cincinnati Children's Hospital Medical Center, Cincinnati. Electronic address: jeff.epstein@cchmc.org. 2. Nationwide Children's Hospital, Columbus. 3. Cincinnati Children's Hospital Medical Center, Cincinnati. 4. University of Ottawa, Ottawa, Ontario, Canada, and the Research Institute at Children's Hospital of Eastern Ontario, Ottawa. 5. Children's Home of Cincinnati. 6. Virginia Commonwealth University, Richmond.
Abstract
OBJECTIVE: The development of attention-deficit/hyperactivity disorder (ADHD) care quality measurements is a prerequisite to improving the quality of community-based pediatric care of children with ADHD. Unfortunately, the evidence base for existing ADHD care quality metrics is poor. The objective of this study was to identify which components of ADHD care best predict patient outcomes. METHOD: Parents of 372 medication-naïve children in grades 1 to 5 presenting to their community-based pediatrician (N = 195) for an ADHD-related concern and who were subsequently prescribed ADHD medication were identified. Parents completed the Vanderbilt ADHD Parent Rating Scale (VAPRS) at the time ADHD was raised as a concern and then approximately 12 months after starting ADHD medication. Each patient's chart was reviewed to measure 12 different components of ADHD care. RESULTS: Across all children, the mean decrease in VAPRS total symptom score during the first year of treatment was 11.6 (standard deviation 10.1). Of the 12 components of ADHD care, shorter times to first contact and more teacher ratings collected in the first year of treatment significantly predicted greater decreases in patient total symptom scores. Notably, it was timeliness of contacts, defined as office visits, phone calls, or email communication, that predicted more ADHD symptom decreases. Office visits alone, in terms of number or timeliness, did not predict patient outcomes. CONCLUSION: The magnitude of ADHD symptom decrease that can be achieved with the use of ADHD medications was associated with specific components of ADHD care. Future development and modifications of ADHD quality care metrics should include these ADHD care components.
OBJECTIVE: The development of attention-deficit/hyperactivity disorder (ADHD) care quality measurements is a prerequisite to improving the quality of community-based pediatric care of children with ADHD. Unfortunately, the evidence base for existing ADHD care quality metrics is poor. The objective of this study was to identify which components of ADHD care best predict patient outcomes. METHOD: Parents of 372 medication-naïve children in grades 1 to 5 presenting to their community-based pediatrician (N = 195) for an ADHD-related concern and who were subsequently prescribed ADHD medication were identified. Parents completed the Vanderbilt ADHD Parent Rating Scale (VAPRS) at the time ADHD was raised as a concern and then approximately 12 months after starting ADHD medication. Each patient's chart was reviewed to measure 12 different components of ADHD care. RESULTS: Across all children, the mean decrease in VAPRS total symptom score during the first year of treatment was 11.6 (standard deviation 10.1). Of the 12 components of ADHD care, shorter times to first contact and more teacher ratings collected in the first year of treatment significantly predicted greater decreases in patient total symptom scores. Notably, it was timeliness of contacts, defined as office visits, phone calls, or email communication, that predicted more ADHD symptom decreases. Office visits alone, in terms of number or timeliness, did not predict patient outcomes. CONCLUSION: The magnitude of ADHD symptom decrease that can be achieved with the use of ADHD medications was associated with specific components of ADHD care. Future development and modifications of ADHD quality care metrics should include these ADHD care components.
Authors: Mark Wolraich; Lawrence Brown; Ronald T Brown; George DuPaul; Marian Earls; Heidi M Feldman; Theodore G Ganiats; Beth Kaplanek; Bruce Meyer; James Perrin; Karen Pierce; Michael Reiff; Martin T Stein; Susanna Visser Journal: Pediatrics Date: 2011-10-16 Impact factor: 7.124
Authors: Michael Gordon; Kevin Antshel; Stephen Faraone; Russell Barkley; Larry Lewandowski; James J Hudziak; Joseph Biederman; Charles Cunningham Journal: J Atten Disord Date: 2006-02 Impact factor: 3.256
Authors: Bonnie T Zima; J Michael Murphy; Sarah Hudson Scholle; Kimberly Eaton Hoagwood; Ramesh C Sachdeva; Rita Mangione-Smith; Donna Woods; Hayley S Kamin; Michael Jellinek Journal: Pediatrics Date: 2013-03 Impact factor: 7.124
Authors: Michael Schoenbaum; Jürgen Unützer; Daniel McCaffrey; Naihua Duan; Cathy Sherbourne; Kenneth B Wells Journal: Health Serv Res Date: 2002-10 Impact factor: 3.402
Authors: Jeffery N Epstein; Joshua M Langberg; Philip K Lichtenstein; Mekibib Altaye; William B Brinkman; Katherine House; Lori J Stark Journal: Arch Pediatr Adolesc Med Date: 2010-02
Authors: Gregory A Fabiano; William E Pelham; Erika K Coles; Elizabeth M Gnagy; Andrea Chronis-Tuscano; Briannon C O'Connor Journal: Clin Psychol Rev Date: 2008-11-11
Authors: David J Kolko; John Campo; Amy M Kilbourne; Jonathan Hart; Dara Sakolsky; Stephen Wisniewski Journal: Pediatrics Date: 2014-03-24 Impact factor: 7.124
Authors: Rosanna Breaux; Daniel A Waschbusch; Rebecca Marshall; Hugh Humphrey; William E Pelham; James G Waxmonsky Journal: Evid Based Pract Child Adolesc Ment Health Date: 2020-03-24
Authors: Carol M Rockhill; L Lee Carlisle; Pingping Qu; Ann Vander Stoep; William French; Chuan Zhou; Kathleen Myers Journal: J Child Adolesc Psychopharmacol Date: 2020-03-11 Impact factor: 2.576
Authors: David J Kolko; Jonathan A Hart; John Campo; Dara Sakolsky; Jeffrey Rounds; Mark L Wolraich; Stephen R Wisniewski Journal: Clin Pediatr (Phila) Date: 2020-07 Impact factor: 1.168